Ewing's U: Dr. Grohar Clinical Trial Update on Trabectedin and Irinotecan

Ewing's U
Written by Piero Spada

Dr. Grohar provides an update on Phase I results of SARC037 – a clinical trial of Trabectedin in combination with Irinotecan.We also touch on the recently opened study at CHOP utilizing a similar targeted agent, Lurbinectedin.

Piero Spada
Previous

Ewing’s U: Dr. Loeb on DFMO for Ewing's Sarcoma
Next

Ewing’s U: Decision Aid for Surgical Options in the Lower Extremity with Janet Panoch, PhD